D.E. Shaw & Co
BLUE

D.E. Shaw & Co’s bluebird bio BLUE Stock Holding History

D.E. Shaw & Co’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,000
Closed -$138K – 4456
2022
Q4 		$138K Hold
1,000
– – ﹤0.01% 4329
2022
Q3 		$127K Hold
1,000
– – ﹤0.01% 4562
2022
Q2 		$83K Hold
1,000
– – ﹤0.01% 4765
2022
Q1 		$97K Sell
1,000
-1,000
-50% -$132K ﹤0.01% 5001
2021
Q4 		$400K Sell
2,000
-3,196
-62% -$754K ﹤0.01% 4529
2021
Q3 		$1.29M Buy
5,196
+3,652
+237% +$1.04M ﹤0.01% 3400
2021
Q2 		$640K Sell
1,544
-772
-33% -$306K ﹤0.01% 3891
2021
Q1 		$905K Sell
2,316
-3,837
-62% -$1.89M ﹤0.01% 3192
2020
Q4 		$3.45M Buy
6,153
+749
+14% +$475K ﹤0.01% 2156
2020
Q3 		$3.78M Sell
5,404
-1,544
-22% -$1.2M ﹤0.01% 1903
2020
Q2 		$5.49M Buy
6,948
+1,544
+29% +$1.16M 0.01% 1597
2020
Q1 		$3.22M Sell
5,404
-1,930
-26% -$1.88M 0.01% 1800
2019
Q4 		$8.34M Buy
7,334
+633
+9% +$688K 0.01% 1335
2019
Q3 		$7.97M Buy
6,701
+1,104
+20% +$1.69M 0.01% 1321
2019
Q2 		$9.22M Buy
5,597
+1,737
+45% +$3M 0.01% 1179
2019
Q1 		$7.87M Buy
3,860
+85
+2% +$150K 0.01% 1263
2018
Q4 		$4.85M Sell
3,775
-2,972
-44% -$4.56M 0.01% 1529
2018
Q3 		$12.8M Buy
6,747
+1,814
+37% +$3.75M 0.02% 982
2018
Q2 		$10M Sell
4,933
-903
-15% -$2.06M 0.01% 1079
2018
Q1 		$12.9M Buy
5,836
+2,702
+86% +$6.87M 0.02% 862
2017
Q4 		$7.23M Buy
3,134
+1,320
+73% +$2.68M 0.01% 1238
2017
Q3 		$3.23M Buy
+1,814
New +$2.53M 0.01% 1699
2015
Q4 		– Sell
-3,621
Closed -$4.01M – 3792
2015
Q3 		$4.01M Buy
3,621
+1,483
+69% +$2.7M 0.01% 1559
2015
Q2 		$4.66M Buy
+2,138
New +$4.36M 0.01% 1525

Other funds holding BLUE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

D.E. Shaw & Co's BLUE Position: Q3 2024 in Review

D.E. Shaw & Co sold out of bluebird bio (BLUE) in Q3 2024, closing a stake of 5,859 shares — an estimated $115K sold.

D.E. Shaw & Co first reported a position in BLUE in Q4 2014 and held it in 29 quarters. The position peaked at $20M in Q4 2017. 140 funds tracked by Wall St. Rank hold BLUE as of Q3 2024.

  • D.E. Shaw & Co reported no remaining bluebird bio position as of Q3 2024 after selling out during the quarter.
  • D.E. Shaw & Co sold 5,859 bluebird bio shares in Q3 2024, an estimated $115K.
  • D.E. Shaw & Co first reported a position in bluebird bio in Q4 2014 and held it in 29 quarters.
  • D.E. Shaw & Co's bluebird bio position peaked at $20M in Q4 2017.
  • 140 funds tracked by Wall St. Rank held bluebird bio as of Q3 2024.

Based on D.E. Shaw & Co's 13F filing for Q3 2024, filed 14 Nov 2024.